Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00379093
Other study ID # NIAAA-MOO-013937
Secondary ID NIH Grant 5 RO1
Status Completed
Phase Phase 2
First received September 19, 2006
Last updated July 10, 2009
Start date August 2003
Est. completion date July 2008

Study information

Verified date July 2009
Source National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

Older persons who drink can be vulnerable to negative consequences of drinking. This trial aims to prevent harm from alcohol use in older adults through a program of screening and brief advice followed up with several health education phone calls.


Description:

Approximately 50% of persons aged 65 years and older drink alcohol. Older persons are particularly susceptible to adverse consequences of drinking such as falls, depression, sleep disorders, stomach upset, hypertension, and alcohol/drug interactions. This is because of age-related changes in the body that affect how older persons react to alcohol and also because of the age-associated increases in illness and medication use.

In the current project we aim to see if screening and brief advice given to older risky drinkers in a physician's office followed by up to 3 health education phone calls may reduce their risks associated with alcohol use. We plan to use a newly developed and tested measure, the Comorbidity Alcohol Risk Evaluation Tool (CARET), to screen for older persons (aged 55 and older) whose use of alcohol alone or in combination with their illnesses, symptoms, and medication use may be causing them harm, or increasing their risk for harm. Persons whose responses on the CARET indicate they might be risky drinkers will be randomized to receive either a brief intervention to reduce their risks or usual care.

The intervention will have the following components:

A) At the time of the recruitment visit, all intervention group patients will receive:

1. A personalized risk report;

2. An educational booklet titled "Healthy Drinking as You Age";

3. A drinking diary;

4. Brief advice to reduce their drinking by their physicians;

B) After the recruitment visit, all intervention group patients will receive up to 3 telephone calls from a health educator. After each call, intervention group patients may choose to receive a letter updating their health risks. Also, at the conclusion of their interaction with the health educator, they may choose to have a letter summarizing the calls sent to their physician.

At the time of the recruitment visit, control group patients will receive a booklet on a variety of healthy behaviors titled "Healthy Living as You Age." Both control and intervention group patients will receive a telephone call from a research associate 3 months and 12 months after initial enrollment in the study to administer the CARET again.

We will analyze our results to look for differences between the intervention and control groups at 12 months in the a) proportions of them identified as risky drinkers by the CARET; b) the amount they drink; c) the numbers of risks identifying those persons who are still risky drinkers and d) the difference in their expectations regarding aging.


Recruitment information / eligibility

Status Completed
Enrollment 631
Est. completion date July 2008
Est. primary completion date April 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 55 Years and older
Eligibility Inclusion Criteria:

- At least 55 years of age

- Seeing a participating physician (internists or family physicians employed at any of the participating sites)

- Have had at least one alcoholic drink in the last week

Exclusion Criteria:

- Too ill to participate

- Have received substance abuse services in past 3 months

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Intervention

Behavioral:
Brief advice
The intervention will have the following components: A) At the time of the recruitment visit, all intervention group patients will receive: A personalized risk report; An educational booklet titled "Healthy Drinking as You Age"; A drinking diary; Brief advice to reduce their drinking by their physicians; B) After the recruitment visit, all intervention group patients will receive up to 3 telephone calls from a health educator. After each call, intervention group patients may choose to receive a letter updating their health risks. Also, at the conclusion of their interaction with the health educator, they may choose to have a letter summarizing the calls sent to their physician.

Locations

Country Name City State
United States UCLA Department of Medicine, Geriatrics Research Center Los Angeles California

Sponsors (1)

Lead Sponsor Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reducing at-risk drinking 12 month Yes
Secondary Reducing alcohol use 12 month Yes
Secondary Reducing the number of risks among those still considered at-risk drinkers. 12 month Yes
See also
  Status Clinical Trial Phase
Withdrawn NCT01539954 - Computerized Alcohol Screening for Children and Adolescents N/A
Completed NCT01544218 - Validating NIAAA Screen Guide in YCMC N/A
Active, not recruiting NCT01655615 - Does Delaying Adolescent Substance Use Lead to Improved Cognitive Function and Reduce Risk for Addiction? N/A
Completed NCT00202514 - Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms Phase 2/Phase 3
Completed NCT00427206 - Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing Phase 4
Completed NCT00132262 - Brief Intervention to Reduce Injury in Minorities N/A
Completed NCT02407340 - Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder Phase 1
Completed NCT00734656 - Pharmacogenetics of Alcohol: Treatment Implications N/A
Completed NCT00402571 - Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics Phase 4
Completed NCT00802321 - Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects N/A